Bulletin
Investor Alert

Market Pulse Archives

March 26, 2020, 11:56 a.m. EDT

Dynavax's stock rises 10% on expanded CEPI partnership

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Dynavax Technologies Corp. (DVAX)
  • X
    GSK PLC ADR (GSK)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Shares of Dynavax Technologies Corp. /zigman2/quotes/203017054/composite DVAX +6.42% gained 10% in trading on Thursday after the company said it's making its adjuvant technology available to companies developing COVID-19 vaccines through a partnership with the Coalition for Epidemic Preparedness Innovations (CEPI), a not-for-profit organization in Oslo that has provided funding to a handful of vaccine developers in this pandemic. Dynavax's adjuvant technology can help provide an increased immune response to a vaccine; the biopharmaceutical company is also working with the University of Queensland, Australia, on vaccine development through a CEPI deal. GlaxoSmithKline /zigman2/quotes/209463850/composite GSK -0.81% , which is lending its adjuvant technology to COVID-19 vaccine development plans, has also partnered with CEPI, the University of Queensland, and Clover Biopharmaceuticals Inc., a Chinese biotechnology company, the same as Dynavax. Dynavax's stock is down 42% year-to-date. The S&P 500 /zigman2/quotes/210599714/realtime SPX +2.47% has dropped 23%.

/zigman2/quotes/203017054/composite
US : U.S.: Nasdaq
$ 12.43
+0.75 +6.42%
Volume: 3.02M
May 27, 2022 4:00p
P/E Ratio
16.25
Dividend Yield
N/A
Market Cap
$1.48 billion
Rev. per Employee
$1.50M
loading...
/zigman2/quotes/209463850/composite
US : U.S.: NYSE
$ 44.06
-0.36 -0.81%
Volume: 5.74M
May 27, 2022 4:00p
P/E Ratio
15.98
Dividend Yield
4.54%
Market Cap
$111.59 billion
Rev. per Employee
$552,510
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,158.24
+100.40 +2.47%
Volume: 2.17B
May 27, 2022 5:49p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.